ODI Pharma AB (XSAT:ODI) Market Cap: kr46.61 Mil (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ODI ODI Pharma AB XSAT:ODI
46 GF Score
Price kr2.54
GF Value kr9.52
Valuation Significantly Undervalued
View Full Analysis

What is ODI Pharma AB Market Cap?

ODI Pharma AB XSAT:ODI +3.25% 46 Market Cap is kr46.61 Mil as of Jul. 16, 2026. GuruFocus rates XSAT:ODI with a GF Score™ of 46/100 and a GF Value™ of kr9.52 (Significantly Undervalued). Among 1,024 Drug Manufacturers companies, ODI Pharma AB ranks worse than 89.94% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ODI Pharma AB's share price for the quarter that ended in Mar. 2026 was kr3.66. ODI Pharma AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.35 Mil. Therefore, ODI Pharma AB's market cap for the quarter that ended in Mar. 2026 was kr67.15 Mil.

ODI Pharma AB's quarterly market cap increased from Sep. 2025 (kr23.10 Mil) to Dec. 2025 (kr79.26 Mil) but then declined from Dec. 2025 (kr79.26 Mil) to Mar. 2026 (kr67.15 Mil).

ODI Pharma AB's annual market cap increased from Jun. 2023 (kr80.66 Mil) to Jun. 2024 (kr109.58 Mil) but then declined from Jun. 2024 (kr109.58 Mil) to Jun. 2025 (kr39.96 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ODI Pharma AB's Enterprise Value for Today is kr42.42 Mil.


ODI Pharma AB  (XSAT:ODI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


ODI Pharma AB Market Cap Related Terms


ODI Pharma AB Market Cap Historical Data

* Premium members only.

The historical data trend for ODI Pharma AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB Market Cap Chart

ODI Pharma AB Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
Get a 7-Day Free Trial 65.44 82.19 80.66 109.58 39.96

ODI Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.34 39.96 23.10 79.26 67.15

XSAT:ODI vs ZTS, UTHR, VTRS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ODI Pharma AB Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's Market Cap distribution charts can be found below:

* The bar in red indicates where ODI Pharma AB's Market Cap falls into.


XSAT:ODI
46GF Score
ODI Pharma AB XSAT:ODI
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ODI Pharma AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ODI Pharma AB's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=kr2.18*18.330
=kr39.96

ODI Pharma AB's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=kr3.66*18.348
=kr67.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of kr46.61 Mil mean?
ODI Pharma AB (XSAT:ODI) has a Market Cap of kr46.61 Mil as of Jul. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ODI Pharma AB and its competitors. According to the industry distribution chart, ODI Pharma AB ranks #921 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 89.9%.
Is ODI Pharma AB's Market Cap too high?
ODI Pharma AB's current Market Cap is kr46.61 Mil. Based on the distribution chart, ODI Pharma AB ranks #921 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ODI Pharma AB has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ODI Pharma AB ranks #921 out of 1024 companies for Market Cap. This places ODI Pharma AB in the lower half of its industry. The industry median Market Cap is 219.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 219.58, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ODI Pharma AB and its competitors. For the Drug Manufacturers industry, the median Market Cap is 219.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ODI Pharma AB's current Market Cap is kr46.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, ODI Pharma AB (XSAT:ODI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr9.52, compared to a current price of kr2.54 — trading 73.3% below its estimated fair value. The current Market Cap is kr46.61 Mil. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ODI Pharma AB (XSAT:ODI), the current Market Cap is kr46.61 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of kr2.54 is trading 73.3% below its estimated GF Value™ of kr9.52. GuruFocus considers ODI Pharma AB to be Significantly Undervalued.

Key valuation signals for XSAT:ODI:

  • Market Cap: kr46.61 Mil
  • GF Value™: kr9.52 vs. price of kr2.54 (73.3% below fair value)
  • GF Score™: 46/100

No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ODI Pharma AB Business Description

Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
46GF Score

Get the complete analysis for XSAT:ODI

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.54
Price
kr9.52
GF Value